Elucent Medical

Prior to Elucent, Ms. King led NeuWave Medical, a Madison, WI based start-up that developed and commercialized a device to ablate cancer tumors in liver, kidney, lung and bone. Ms. King led NeuWave Medical for seven years, successfully raising $33 M in venture capital and doubling revenue each year. NeuWave had a very successful exit, selling to JnJ Ethicon in 2016. Prior to joining the start-up world, Ms. King was a GE company officer while leading the $1.2 B Global Interventional Cardiology and Surgery business. Raised in San Francisco, CA, she is a graduate of UC Davis in Economics. Jason Hiltner PhD